2022 Q1 Form 10-Q Financial Statement

#000156276222000252 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $2.030M $612.9K $2.458M
YoY Change -17.42% -77.79% -45.99%
Cost Of Revenue $1.175M $979.7K $1.042M
YoY Change 12.78% -2.59% -34.25%
Gross Profit $854.6K -$366.8K $1.416M
YoY Change -39.64% -120.92% -52.26%
Gross Profit Margin 42.11% -59.85% 57.61%
Selling, General & Admin $1.805M $1.108M $2.186M
YoY Change -17.45% -18.29% 6.39%
% of Gross Profit 211.17% 154.41%
Research & Development $702.2K $1.508M $724.0K
YoY Change -3.0% -56.84%
% of Gross Profit 82.17% 51.13%
Depreciation & Amortization $124.3K $259.0K $141.6K
YoY Change -12.2% 60.28% -18.6%
% of Gross Profit 14.55% 10.0%
Operating Expenses $2.631M $2.798M $3.077M
YoY Change -14.48% 26.55% -21.24%
Operating Profit -$1.777M -$3.165M -$1.661M
YoY Change 6.97% 591.11% 76.57%
Interest Expense $159.8K -$125.3K $32.52K
YoY Change 391.53% 56.21% -57.87%
% of Operating Profit
Other Income/Expense, Net -$156.5K -$891.1K -$32.99K
YoY Change 374.48% -56.14%
Pretax Income -$1.933M -$4.150M -$1.694M
YoY Change 14.13% 241.06% 66.75%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.900M -$4.150M -$1.694M
YoY Change 12.18% 241.06% 66.75%
Net Earnings / Revenue -93.62% -677.06% -68.92%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$33.78K -$74.89K -$30.57K
COMMON SHARES
Basic Shares Outstanding 58.57M 55.41M 55.41M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.455M $735.4K $1.027M
YoY Change 41.66% -77.6% 393.33%
Cash & Equivalents $1.455M $735.4K $1.027M
Short-Term Investments
Other Short-Term Assets $333.2K $227.5K $342.4K
YoY Change -2.67% -16.6% -51.3%
Inventory
Prepaid Expenses
Receivables $491.0K $578.3K $1.366M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.279M $1.541M $3.897M
YoY Change -41.52% -67.93% 37.79%
LONG-TERM ASSETS
Property, Plant & Equipment $1.132M $1.188M $1.132M
YoY Change 0.0% 11274.9% 3324.01%
Goodwill $411.2K $411.2K $496.4K
YoY Change -17.16% -17.16%
Intangibles $1.016M $1.125M $1.275M
YoY Change -20.36% -17.8%
Long-Term Investments
YoY Change
Other Assets $157.4K $173.3K $314.7K
YoY Change -50.0% 586.98% 372.18%
Total Long-Term Assets $2.717M $2.897M $4.399M
YoY Change -38.24% -13.87% 1.59%
TOTAL ASSETS
Total Short-Term Assets $2.279M $1.541M $3.897M
Total Long-Term Assets $2.717M $2.897M $4.399M
Total Assets $4.996M $4.438M $8.296M
YoY Change -39.78% -45.67% 15.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.503M $3.824M $2.244M
YoY Change 56.14% 97.58% -38.08%
Accrued Expenses $835.6K $897.0K $631.1K
YoY Change 32.39% 171.52% -9.24%
Deferred Revenue $377.2K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.521M $888.6K $432.2K
YoY Change 251.83% 38.48% -36.78%
Total Short-Term Liabilities $6.033M $5.996M $4.478M
YoY Change 34.74% 46.94% -31.58%
LONG-TERM LIABILITIES
Long-Term Debt $1.919M $2.538M $1.491M
YoY Change 28.72% 69.3% -9.03%
Other Long-Term Liabilities $1.128M $1.189M $2.058M
YoY Change -45.22% 40.69% 60.24%
Total Long-Term Liabilities $3.047M $3.726M $3.549M
YoY Change -14.16% 58.99% 21.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.033M $5.996M $4.478M
Total Long-Term Liabilities $3.047M $3.726M $3.549M
Total Liabilities $9.080M $9.722M $8.027M
YoY Change 13.12% 51.34% -15.22%
SHAREHOLDERS EQUITY
Retained Earnings -$109.8M -$107.8M -$101.3M
YoY Change 8.39% 8.29%
Common Stock $58.60K $55.41K $55.41K
YoY Change 5.75% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.084M -$5.284M $269.4K
YoY Change
Total Liabilities & Shareholders Equity $4.996M $4.438M $8.296M
YoY Change -39.78% -45.67% 15.9%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.900M -$4.150M -$1.694M
YoY Change 12.18% 241.06% 66.75%
Depreciation, Depletion And Amortization $124.3K $259.0K $141.6K
YoY Change -12.2% 60.28% -18.6%
Cash From Operating Activities -$1.800M -$1.295M -$1.902M
YoY Change -5.36% 56.34% 459.55%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $10.29K $75.85K
YoY Change -100.0% -112.34% 1445.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $10.29K -$126.4K
YoY Change -100.0% -112.34% 516.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.544M 1.479M -221.1K
YoY Change -1250.92% -60.01% -170.32%
NET CHANGE
Cash From Operating Activities -1.800M -1.295M -1.902M
Cash From Investing Activities 0.000 10.29K -126.4K
Cash From Financing Activities 2.544M 1.479M -221.1K
Net Change In Cash 719.7K 193.8K -2.256M
YoY Change -131.91% -93.04% 3349.9%
FREE CASH FLOW
Cash From Operating Activities -$1.800M -$1.295M -$1.902M
Capital Expenditures $0.00 $10.29K $75.85K
Free Cash Flow -$1.800M -$1.305M -$1.978M
YoY Change -8.99% 75.23% 473.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001447380
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
000-53851
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Mobivity Holdings Corp.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3439095
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3133 West Frye Road
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
# 215
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chandler
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85226
CY2022Q1 dei City Area Code
CityAreaCode
877
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
282-7660
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58598885
CY2022Q1 us-gaap Cash
Cash
1455147
CY2021Q4 us-gaap Cash
Cash
735424
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53514
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56340
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
491004
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
578303
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
333207
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
227458
CY2022Q1 us-gaap Assets Current
AssetsCurrent
2279358
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1541185
CY2022Q1 us-gaap Goodwill
Goodwill
411183
CY2021Q4 us-gaap Goodwill
Goodwill
411183
CY2022Q1 mfon Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
1132317
CY2021Q4 mfon Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
1187537
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015690
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
157366
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
173325
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58598885
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58598885
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55410695
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55410695
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1124720
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
41577
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
69052
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
58599
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
55411
CY2022Q1 mfon Equity Amount Payable
EquityAmountPayable
100862
CY2021Q4 mfon Equity Amount Payable
EquityAmountPayable
100862
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
105590137
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102446921
CY2022Q1 us-gaap Assets
Assets
4995914
CY2021Q4 us-gaap Assets
Assets
4437950
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3503464
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3823909
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
305364
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
172239
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
292430
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
495533
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
173379
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
377170
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1479167
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
819531
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
237761
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
229240
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9071
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6033142
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5995745
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1857079
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2498711
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
61794
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
39086
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1127670
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1188589
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3046543
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3726386
CY2022Q1 us-gaap Liabilities
Liabilities
9079685
CY2021Q4 us-gaap Liabilities
Liabilities
9722131
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64983
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52088
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109768386
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107835287
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4083771
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5284181
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4995914
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4437950
CY2022Q1 us-gaap Revenues
Revenues
2029569
CY2021Q1 us-gaap Revenues
Revenues
2457590
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1174948
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1041795
CY2022Q1 us-gaap Gross Profit
GrossProfit
854621
CY2021Q1 us-gaap Gross Profit
GrossProfit
1415795
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1207176
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1289370
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
597501
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
896750
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
702223
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
723950
CY2021Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
8286
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
124312
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
158227
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2631212
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3076583
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1776591
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1660788
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5
CY2022Q1 us-gaap Interest Expense
InterestExpense
159827
CY2021Q1 us-gaap Interest Expense
InterestExpense
32516
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3319
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-474
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-156508
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32985
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1933099
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1693773
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1693773
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12895
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9678
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1945994
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1703451
CY2022Q1 mfon Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.03
CY2021Q1 mfon Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.03
CY2022Q1 mfon Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
57233309
CY2021Q1 mfon Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
55410695
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1744213
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11297
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
589650
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
228623
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
228623
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9678
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1693773
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
269385
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5284181
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2550553
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
6201
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
589650
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12895
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4083771
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1693773
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10705
CY2021Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
8286
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124312
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
141591
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24205
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-98004
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1071359
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
105749
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
70901
CY2022Q1 mfon Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
2822
CY2021Q1 mfon Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
16636
CY2021Q1 mfon Increase Decrease In Contract With Customer Asset Non Current
IncreaseDecreaseInContractWithCustomerAssetNonCurrent
235976
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
108652
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-320445
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
308399
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
133125
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-15775
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-203103
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
248828
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9071
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-138589
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-36130
CY2022Q1 mfon Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
-203791
CY2021Q1 mfon Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
33584
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1813845
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1901959
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75852
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
50588
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126440
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6354
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
141058
CY2021Q1 mfon Payments On Related Party Notes Payable
PaymentsOnRelatedPartyNotesPayable
80000
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2550553
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2544199
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-221058
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10631
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6155
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
719723
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2255612
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
735424
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3282820
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1455147
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1027208
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
29541
CY2022Q1 mfon Fair Value Of Options Issued With Related Party Debt
FairValueOfOptionsIssuedWithRelatedPartyDebt
6201
CY2021Q1 mfon Fixed Assets Contributed By Lessor
FixedAssetsContributedByLessor
110000
CY2021Q1 mfon Initial Rou Asset And Lease Liability
InitialRouAssetAndLeaseLiability
1458527
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable and intellectual property. We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.</span>
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.</span></p>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Reclassifications</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.</span></p>
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53514
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56340
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
85169
CY2022Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2021Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
8286
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1945994
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1703451
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
163734
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
188343
CY2022Q1 us-gaap Marketing Expense
MarketingExpense
10000
CY2021Q1 us-gaap Marketing Expense
MarketingExpense
0
CY2022Q1 us-gaap Cash
Cash
1455147
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1900000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1800000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8300000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4500000
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2550553
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109768386
CY2021Q4 us-gaap Goodwill
Goodwill
411183
CY2022Q1 us-gaap Goodwill
Goodwill
411183
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
776924
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38888
CY2022Q1 mfon Finite Lived Intangible Other
FiniteLivedIntangibleOther
3147
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
741183
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38888
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36004
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
347796
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
73289
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
274507
CY2022Q1 mfon Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
1132317
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1132317
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
237761
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1127670
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1365431
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
241949
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
324221
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
330894
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675
CY2022Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3439617
CY2021Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3426380
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1520744
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
888583
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
344241
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
28733
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1607606
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
242175
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1365431
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
65000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10250
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
337568
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1918873
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2537797
CY2022Q1 us-gaap Interest Expense
InterestExpense
159827
CY2021Q1 us-gaap Interest Expense
InterestExpense
32516
CY2022Q1 mfon Number Of Warrant Holders That Exercised Warrants
NumberOfWarrantHoldersThatExercisedWarrants
17
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3188190
CY2022Q1 mfon Exercise Price
ExercisePrice
0.80
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3188190
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.50
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P3Y
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
382048
CY2021Q1 mfon Equity Amount Payable
EquityAmountPayable
100862
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6007552
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
637500
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
272029
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
126557
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6246466
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6321216
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.83
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.54
CY2021Q1 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
5
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
67500
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.93
CY2021Q2 mfon Call Option Value
CallOptionValue
18628
CY2021Q3 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
1
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7329
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
1.12
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.80
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7397
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
1.16
CY2021Q1 mfon Call Option Value
CallOptionValue
78492
CY2021Q2 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
1
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.48
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7479
CY2021Q3 mfon Call Option Value
CallOptionValue
5606
CY2022Q1 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
1
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2022Q1 mfon Exercise Price
ExercisePrice
0.8289
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7233
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.54
CY2022Q1 mfon Call Option Value
CallOptionValue
81035
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0247
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0101
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7233
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7397
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1436728
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
654663
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
406250
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1685141
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
78420
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1763561
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1763561
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1763561
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5285
CY2022Q1 mfon Number Of Warrant Holders That Exercised Warrants
NumberOfWarrantHoldersThatExercisedWarrants
17
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3188190
CY2022Q1 mfon Exercise Price
ExercisePrice
0.80
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3188190
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.50
CY2022Q1 mfon Warrant Exercisable Period After Issuance Of Financing
WarrantExercisablePeriodAfterIssuanceOfFinancing
P3Y
CY2018Q1 us-gaap Payments For Commissions
PaymentsForCommissions
0

Files In Submission

Name View Source Status
0001562762-22-000252-index-headers.html Edgar Link pending
0001562762-22-000252-index.html Edgar Link pending
0001562762-22-000252.txt Edgar Link pending
0001562762-22-000252-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfon-20220331.xsd Edgar Link pending
mfon-20220331x10q.htm Edgar Link pending
mfon-20220331x10q_htm.xml Edgar Link completed
mfon-20220331xex31_1.htm Edgar Link pending
mfon-20220331xex31_2.htm Edgar Link pending
mfon-20220331xex32_1.htm Edgar Link pending
mfon-20220331_cal.xml Edgar Link unprocessable
mfon-20220331_def.xml Edgar Link unprocessable
mfon-20220331_lab.xml Edgar Link unprocessable
mfon-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending